BTK and hemophagocytic syndrome: We speculate that HLH was likely caused by ibrutinib, although there is currently limited literature reporting cases of drug-induced HLH.[13] Ibrutinib, as a targeted agent, is a covalent inhibitor of Bruton tyrosine kinase (BTK).